Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bristol-Myers Squibb (NY:BMY)

53.83 -0.39 (-0.73%)
Streaming Delayed Price Updated: 1:15 PM EST, Jan 21, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bristol-Myers Squibb

< Previous 1 2
...
23 24 25 26 27 28 29 30 31
...
85 86 Next >
News headline image
2 Pharma Stocks to Buy Hand Over Fist This Month ↗
These drugmakers may not be in perfect health right now, but that shouldn't last much longer. 
Via The Motley Fool
News headline image
3 Under-$10 Biotech Stocks That Could Make You Rich ↗
Discover three under-$10 biotech stocks with potential to make you rich with huge returns on investment through an in-depth analysis. 
Via InvestorPlace
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
3 Undervalued Stocks Ready for a Breakout This Summer ↗
Undervalued breakout stocks are heating up this summer. Discover three hidden gems with strong fundamentals ready to outperform the market. 
Via InvestorPlace
News headline image
Spotlight on Bristol-Myers Squibb: Analyzing the Surge in Options Activity ↗
 
Via Benzinga
News headline image
3 Popular Stocks Trading at 52 Week Lows ↗
Stocks at 52 week lows could provide value, but it's not always a sure thing. 
Via The Motley Fool
News headline image
How Is The Market Feeling About Bristol-Myers Squibb? ↗
 
Via Benzinga
News headline image
Looking At Bristol-Myers Squibb's Recent Unusual Options Activity ↗
 
Via Benzinga
News headline image
What the Options Market Tells Us About Bristol-Myers Squibb ↗
 
Via Benzinga
News headline image
Want $1,000 in Reliable Dividend Income? Invest $11,800 in these 3 Ultra-High-Yield Dividend Stocks. ↗
These three dividend payers could deliver buckets of passive income to patient investors. 
Via The Motley Fool
News headline image
The 7 Best Warren Buffett Stocks to Buy in July 2024 ↗
Some investors may say value investing is dead, but its never a bad time to look at some of the best Warren Buffett stocks to buy 
Via InvestorPlace
News headline image
3 High-Yield S&P 500 Dividend Stocks That You Can Buy With $100 Right Now ↗
After underperforming the benchmark index these stocks offer high dividend yields that are hard to ignore. 
Via The Motley Fool
Topics Stocks
News headline image
Bristol Myers Squibb to Participate in UBS Virtual Targeted Protein Degradation Day
From Bristol Myers Squibb
Via Business Wire
News headline image
What the Options Market Tells Us About Bristol-Myers Squibb ↗
 
Via Benzinga
News headline image
3 Defensive Stocks to Buy During the Market Dip ↗
Clearway, Bristol-Myers Squibb and Universal Corp. are defensive stocks to buy on the dip, offering stable dividends and significant upside. 
Via InvestorPlace
News headline image
3 Reliable Dividend Stocks With Yields Above 5% You Can Buy With $100 in July ↗
Adding these dividend payers to your portfolio is a nearly certain way to boost your passive income stream. 
Via The Motley Fool
News headline image
3 Hidden Stock Gems That Wall Street Is Overlooking ↗
If you play the long game and have a suitable risk tolerance, you can find overlooked stock gems like these three. 
Via InvestorPlace
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
Treasure Hunt: 3 Small-Cap Stocks Wall Street Hasn’t Discovered Yet ↗
Undiscovered small-cap stocks hold the greatest potential for creating investor wealth as they can take off at a moment's notice. 
Via InvestorPlace
News headline image
Is Bristol Myers Squibb Stock a Buy? ↗
Does Bristol Myers have the potential to be a market-beating stock? 
Via The Motley Fool
News headline image
Novo Nordisk Buys 2seventy's Hemophilia A Program, Divestiture Supports Exclusive Focus On Abecma ↗
2seventy Bio finalized an asset purchase agreement with Novo Nordisk involving the Hemophilia A program and in vivo gene editing technology. The 2seventy bio team will join Novo Nordisk, focusing on... 
Via Benzinga
News headline image
You’ve Been Warned! 3 Pharma Stocks to Buy Now or Regret Forever. ↗
Pharmaceutical stocks can be considered risky, but when their trials get approved by FDA, the stock can go to the moon. 
Via InvestorPlace
News headline image
FDA Approves Bristol Myers Squibb's Combination Therapy For Colorectal Cancer Patients With Certain Type Of Gene Mutation ↗
The FDA granted accelerated approval to Bristol Myers Squibb's Krazati (adagrasib) with cetuximab for adult patients with KRASG12C-mutated advanced or metastatic colorectal cancer. 
Via Benzinga
News headline image
7 Dividend Stocks to Buy Now: June 2024 ↗
These dividend stocks to buy now will reward investors with income now and growth as the market breadth expands. 
Via InvestorPlace
News headline image
AbbVie Inc. Dividend Stock Analysis - Saturday, June 22 ↗
Here are some highlights from a detailed, quantitative analysis AbbVie Inc. stock. Let's take a closer look at various factors, such as the stock's value and dividend. 
Via Talk Markets
News headline image
S&P 500 Earnings Dashboard 24Q1 - Saturday, June 22 ↗
Of the 498 companies in the S&P 500 that have reported earnings to date for 24Q1, 78.7% reported above analyst expectations. This compares to a long-term average of 66%. 
Via Talk Markets
Topics Stocks
News headline image
3 No-Brainer Stocks to Buy for Under $100 Right Now ↗
You won't need much money to start investing in these great stocks. 
Via The Motley Fool
News headline image
3 High-Yield Dividend Stocks Near Their 52-Week Lows to Buy and Hold ↗
The pharmaceutical industry giants offer reliable profit growth and above-average dividend yields. 
Via The Motley Fool
News headline image
Bristol Myers Squibb Announces U.S. FDA Accelerated Approval of KRAZATI® (adagrasib) in Combination with Cetuximab for Adult Patients with Previously Treated KRAS G12C-Mutated Locally Advanced or Metastatic Colorectal Cancer (CRC)
From Bristol Myers Squibb
Via Business Wire
News headline image
Gilead Sciences Faces Wall Street Speculation About Obesity Drugs Despite Focus On Liver Treatments ↗
Gilead Sciences faces Wall Street speculation about its potential in the obesity drug market despite its focus on liver treatments. 
Via Benzinga
< Previous 1 2
...
23 24 25 26 27 28 29 30 31
...
85 86 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.